Sophie Bozec holds a PhD in Nutrition, Metabolism and Obesity from the Paris VII University. She is Executive Vice President, R&D Pharmacology and Scientific Communication at Poxel, a French biotech company based in Lyon. Sophie is a cofounder of the company and is leading all pharmacology activities. Sophie worked during many years in drug discovery in metabolic diseases in a large pharmaceutical company.